Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. - Wikidata - awgldk - TriplyDB

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.

http://www.wikidata.org/entity/Q37416216

about

Influence of social contact patterns and demographic factors on influenza simulation results.A systematic review of the health economic consequences of quadrivalent influenza vaccination.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.

P2860

Q36184849-D24AE3FB-4816-44F7-B1CD-4D197E614659 Q38671179-029BDA05-3D50-4BA3-B0DD-78C573C1F901 Q39322780-7BD1A6C1-81C3-4523-81FC-9860449B65A8

P2860

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.

http://www.wikidata.org/entity/Q37416216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@en

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@nl

type

label

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@en

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@nl

prefLabel

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@en

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@nl

P1433

Q37416216-9E5CCD03-834D-445F-BA45-8F0A3FECDCE2

P1476

Q37416216-C60AE2D8-33EF-4DD9-AF9E-5CB30F737957

P2093

Q37416216-1B4B8AD1-D58A-4A33-8CDB-9713DCB64969

Q37416216-1E16BD24-9238-4BAE-A2B3-B7A543568124

Q37416216-2156570F-8527-4A15-BE4E-FB190F45EC7B

Q37416216-35E898DB-7B41-472A-A25B-5D9AED9F9E04

Q37416216-61F5ADA6-AD08-4B1A-BF70-A58D22785FCE

Q37416216-B437090C-0FDD-449C-803D-9D396119143E

Q37416216-B9227441-00D6-4BD1-9E28-ED9051BEC548

Q37416216-C730D10A-5047-45C2-A3F2-1525E4152047

Q37416216-F26C9252-AD9C-4F2B-A333-99D3B2E0A0A4

P2860

Q37416216-0C07400D-6293-4F73-8B3E-702B71577746

Q37416216-2FF5F69E-B11D-41DC-8BED-280A0278A5A8

Q37416216-42B01246-1E41-447E-81FA-E484EA9FACC8

Q37416216-465311FF-ED0F-443A-9801-A793C479A20B

Q37416216-4AB30B51-31A5-40FF-8502-484309074F6F

Q37416216-58D753B8-476A-4ADC-881C-3F21D708F044

Q37416216-63BB6B62-240C-490B-8583-4E9326743EC6

Q37416216-63DB8AE4-E86D-480B-ACAF-44CBC64B0CDD

Q37416216-6A5B17B6-53E6-4CB3-ABD0-600C273167FA

Q37416216-6FEADD9B-4D63-45A6-863E-983E1EA80E71

P2888

Q37416216-BC96A089-7478-48EE-A36F-4B89BB558CFA

P304

Q37416216-03F5DC92-F289-47D4-AE2A-FA164FA088FB

P31

Q37416216-860113EA-8FE3-4FC2-9B4E-5036E26A0234

P356

Q37416216-C26B1672-DA35-42E6-A80B-EC72D80D50CA

P433

Q37416216-34823B52-A035-4AD9-9FF1-591F1F355043

P478

Q37416216-D7D83F18-6198-4D86-8565-04B6C032D746

P50

Q37416216-99678A5C-F79F-40AB-85E5-E0B60275B021

P577

Q37416216-276193E5-C849-4613-A250-4149FAF9175E

P698

Q37416216-8D2A5E04-7CC7-4823-8301-6AED9B88593F

P921

Q37416216-12FCAFC2-0C1E-4532-BF0A-9ED579823C8D

P932

Q37416216-3D92FAC0-4D42-44EE-9F0C-F0548921AE1C

P356

S40273-016-0443-7

P1433

PharmacoEconomics

P1476

Cost-Utility of Quadrivalent V ...... ed Dynamic Transmission Model.

@en

P2093

Anastassia Anastassopoulou

http://www.w3.org/2001/XMLSchema#string

Barbara Poulsen Nautrup

http://www.w3.org/2001/XMLSchema#string

Ilse Van Vlaenderen

http://www.w3.org/2001/XMLSchema#string

Laure-Anne Van Bellinghen

http://www.w3.org/2001/XMLSchema#string

Maarten Postma

http://www.w3.org/2001/XMLSchema#string

Markus Schwehm

http://www.w3.org/2001/XMLSchema#string

Martin Eichner

http://www.w3.org/2001/XMLSchema#string

Robert Welte

http://www.w3.org/2001/XMLSchema#string

Ruprecht Schmidt-Ott

http://www.w3.org/2001/XMLSchema#string

P2860

Social contacts and mixing patterns relevant to the spread of infectious diseases

Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07.

The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies.

Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany

Cost-utility analysis of a preventive home visit program for older adults in Germany.

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.

P2888

s40273-016-0443-7

P304

1299-1308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-016-0443-7

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Christiaan Dolk

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27647004

http://www.w3.org/2001/XMLSchema#string

P921

P932

5110585

http://www.w3.org/2001/XMLSchema#string